Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis

Background: To evaluate immunotherapy against canine visceral leishmaniasis, Leishmania ma­jor antigen and heat-killed Mycobacterium vaccae (SRL172) were used as stimulators of immune de­fense mechanisms and the results were compared with standard chemotherapy meglumine antimoni­ate. Methods: Ninet...

Full description

Bibliographic Details
Main Authors: Sh Jamshidi, R Avizeh, M Mohebali, S Bokaie
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2011-09-01
Series:Iranian Journal of Parasitology
Subjects:
Online Access:https://ijpa.tums.ac.ir/index.php/ijpa/article/view/185
_version_ 1798027422186078208
author Sh Jamshidi
R Avizeh
M Mohebali
S Bokaie
author_facet Sh Jamshidi
R Avizeh
M Mohebali
S Bokaie
author_sort Sh Jamshidi
collection DOAJ
description Background: To evaluate immunotherapy against canine visceral leishmaniasis, Leishmania ma­jor antigen and heat-killed Mycobacterium vaccae (SRL172) were used as stimulators of immune de­fense mechanisms and the results were compared with standard chemotherapy meglumine antimoni­ate. Methods: Nineteen mongrel dogs aging 1-3 years old were used in this experiment. Infection was carried out in 15 out of 19 dogs using L. infantum, isolated from a naturally infected poly-symptomatic dog. Results: All the cases showed positive serologic results by direct agglutination test during 30-60 days following inoculation. In the first group, which was under chemotherapy (GlucantimeR), one of the members showed recurrence of the disease despite rapid effect of the therapeutic protocol. Im­munotherapy using SRL172 caused complete cleaning of the parasite in group 2, but the speed was less than Glucantime. Immunotherapy using L. major antigen combined with M. vaccae in group 3 and combine administration of immunotherapy and chemotherapy in group 4 both were with relapsing of one case in each group. Group 5 and 6 were consisted of positive and negative con­trol dogs, respectively. Conclusion: Immunotherapy seems to be an adjuvant in treatment of canine leishmaniasis but it needs more investigation for final confirmation.
first_indexed 2024-04-11T18:51:11Z
format Article
id doaj.art-dce46239f3b744d7b0f73dde9445b7b4
institution Directory Open Access Journal
issn 1735-7020
2008-238X
language English
last_indexed 2024-04-11T18:51:11Z
publishDate 2011-09-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Parasitology
spelling doaj.art-dce46239f3b744d7b0f73dde9445b7b42022-12-22T04:08:23ZengTehran University of Medical SciencesIranian Journal of Parasitology1735-70202008-238X2011-09-0163Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral LeishmaniasisSh Jamshidi0R Avizeh1M Mohebali2S Bokaie3Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, IranDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University, Ahvaz, IranDept. of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranDepartment of Food Hygiene, Faculty of Veterinary Medicine, University of Tehran, Tehran, IranBackground: To evaluate immunotherapy against canine visceral leishmaniasis, Leishmania ma­jor antigen and heat-killed Mycobacterium vaccae (SRL172) were used as stimulators of immune de­fense mechanisms and the results were compared with standard chemotherapy meglumine antimoni­ate. Methods: Nineteen mongrel dogs aging 1-3 years old were used in this experiment. Infection was carried out in 15 out of 19 dogs using L. infantum, isolated from a naturally infected poly-symptomatic dog. Results: All the cases showed positive serologic results by direct agglutination test during 30-60 days following inoculation. In the first group, which was under chemotherapy (GlucantimeR), one of the members showed recurrence of the disease despite rapid effect of the therapeutic protocol. Im­munotherapy using SRL172 caused complete cleaning of the parasite in group 2, but the speed was less than Glucantime. Immunotherapy using L. major antigen combined with M. vaccae in group 3 and combine administration of immunotherapy and chemotherapy in group 4 both were with relapsing of one case in each group. Group 5 and 6 were consisted of positive and negative con­trol dogs, respectively. Conclusion: Immunotherapy seems to be an adjuvant in treatment of canine leishmaniasis but it needs more investigation for final confirmation.https://ijpa.tums.ac.ir/index.php/ijpa/article/view/185Canine visceral leishmaniasisImmunotherapyGlucantimeMycobacterium vaccae
spellingShingle Sh Jamshidi
R Avizeh
M Mohebali
S Bokaie
Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
Iranian Journal of Parasitology
Canine visceral leishmaniasis
Immunotherapy
Glucantime
Mycobacterium vaccae
title Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
title_full Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
title_fullStr Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
title_full_unstemmed Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
title_short Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
title_sort immunotherapy using autoclaved l major antigens and m vaccae with meglumine antimoniate for the treatment of experimental canine visceral leishmaniasis
topic Canine visceral leishmaniasis
Immunotherapy
Glucantime
Mycobacterium vaccae
url https://ijpa.tums.ac.ir/index.php/ijpa/article/view/185
work_keys_str_mv AT shjamshidi immunotherapyusingautoclavedlmajorantigensandmvaccaewithmeglumineantimoniateforthetreatmentofexperimentalcaninevisceralleishmaniasis
AT ravizeh immunotherapyusingautoclavedlmajorantigensandmvaccaewithmeglumineantimoniateforthetreatmentofexperimentalcaninevisceralleishmaniasis
AT mmohebali immunotherapyusingautoclavedlmajorantigensandmvaccaewithmeglumineantimoniateforthetreatmentofexperimentalcaninevisceralleishmaniasis
AT sbokaie immunotherapyusingautoclavedlmajorantigensandmvaccaewithmeglumineantimoniateforthetreatmentofexperimentalcaninevisceralleishmaniasis